Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 22.22 is 22% below its 3-year average of 28.62, around the middle of its 3-year range (0.00–57.95).
As of the fiscal period ended Tuesday, June 30, 2026. 9.74% below its 12-month average of 24.62.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 22.22.
CURRENT RATIO
22.22
CURRENT RATIO AVG TTM
24.62
CURRENT RATIO AVG 3Y
27.62
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.74%
CURRENT VS 3Y AVG
-19.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.05
median of 419 covered companies
CURRENT VS SECTOR MEDIAN
+628.51%
vs the sector median at left
Market Cap
$6.50B
Current Ratio
2.20
TTM Avg
1.79
3Y Avg
1.77
5Y Avg
1.94
Market Cap
$5.53B
Current Ratio
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$5.27B
Current Ratio
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
Market Cap
$5.20B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CG Oncology Inc. (CGON) | $6.06B | 22.22 | 24.62 | 27.62 | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.50B | 2.20 | 1.79 | 1.77 | 1.94 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | 17.85 | 17.70 | 17.06 | 17.77 |
| GRAIL Inc. (GRAL)vs › | $6.61B | 10.95 | 11.32 | 6.44 | 5.89 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.62B | 0.93 | 1.84 | 2.80 | 3.67 |
| Chemed Corporation (CHE)vs › | $6.68B | 0.91 | 1.21 | 1.24 | 1.14 |
| Doximity, Inc. (DOCS)vs › | $5.35B | 6.08 | 6.53 | 6.56 | 6.07 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 13.57 | 9.78 | 9.13 | 11.38 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 4.20 | 4.30 | 4.12 | 3.47 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 7.02 | 8.28 | 8.59 | 7.77 |
Current Ratio
22.22
Quick Ratio
22.20
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 22.22 |
| 2026-03-31 | 31.30 |
| 2025-12-31 | 24.63 |
| 2025-09-30 | 22.79 |
| 2025-06-30 | 22.15 |
| 2025-03-31 | 30.97 |
| 2024-12-31 | 35.30 |
| 2024-09-30 | 35.32 |
| 2024-06-30 | 47.57 |
| 2024-03-31 | 57.95 |
| 2023-12-31 | 13.62 |
| 2023-09-30 | 17.92 |
| 2023-06-30 | 57.95 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 9.54 |
